Delivery Order SPE2DB22D2009-SPE2DB25FM0ME
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,779.14 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $11,391.80 to AmerisourceBergen Drug Corp for the supply of Shingrix vial kits, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The delivery will be fulfilled from the...
- The Defense Logistics Agency awarded a $4,333.37 firm fixed price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 1, 2025. This firm fixed price contract, awarded on July 31, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 1, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $7,229.72 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $51,263.00 to supply Shingrix vial kits, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for SHINGRIX vial kits on August 7, 2025. This competitive award, which carries a firm fixed price, was executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The contract type and pricing structure reflect the established...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $17,282.29 under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0MEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,371.95 to AmerisourceBergen Drug Corp for Shingrix vial kits, effective July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and related medical commodities. Through this delivery order mechanism, the company continues to fulfill critical pharmaceutical needs for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/24/25 |